TELA Bio, Inc. (TELA)

NGM – Real vaqt narxi. Valyuta: USD

0.71

-0.03 (-4.65%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

0.67

-0.03 (-4.76%)

Bozordan keyin: Jun 26, 2026, 5:05 PM EDT

13.05.2026

TELA Bio, Inc. (TELA) Q1 2026 Earnings Call Transcript

12.05.2026

TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates

TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.25 per share a year ago.

12.05.2026

TELA Bio Reports First Quarter 2026 Financial Results

MALVERN, Pa., May 12, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the first quarter ended March 31, 2026.

07.05.2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 89,250 shares of its common stock to 12 newly-hired employees, with a grant date of May 5, 2026 (the "Grant Date").

21.04.2026

TELA Bio to Announce First Quarter 2026 Financial Results

MALVERN, Pa., April 21, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report first quarter 2026 financial results on Tuesday, May 12, 2026. TELA Bio's management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

25.03.2026

TELA Bio Analysts Cut Their Forecasts After Q4 Results

TELA Bio, Inc. (NASDAQ: TELA) reported mixed results for the fourth quarter on Tuesday.

24.03.2026

TELA Bio, Inc. (TELA) Q4 2025 Earnings Call Transcript

Videolar

No Data

There is no data to display

TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results

MALVERN, Pa., March 24, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025.

20.02.2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Feb. 20, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 8,550 shares of its common stock to three newly-hired employees, with a grant date of February 18, 2026 (the "Grant Date"). The restricted stock units were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individual's employment compensation and were granted as an inducement material to his or her acceptance of employment with TELA Bio.

TELA Bio, Inc. (TELA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

TELA Bio, Inc. (TELA)

TELA Bio, Inc. (TELA) Q1 2026 Earnings Call Transcript

TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates

TELA Bio Reports First Quarter 2026 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio to Announce First Quarter 2026 Financial Results

TELA Bio Analysts Cut Their Forecasts After Q4 Results

TELA Bio, Inc. (TELA) Q4 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

TELA Bio Reports First Quarter 2026 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio, Inc. (TELA) Q1 2026 Earnings Call Transcript

TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates

TELA Bio Reports First Quarter 2026 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio to Announce First Quarter 2026 Financial Results

TELA Bio Analysts Cut Their Forecasts After Q4 Results

TELA Bio, Inc. (TELA) Q4 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

TELA Bio Reports First Quarter 2026 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Search stocks

TELA Bio, Inc. (TELA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

TELA Bio, Inc. (TELA)

TELA Bio, Inc. (TELA) Q1 2026 Earnings Call Transcript

TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates

TELA Bio Reports First Quarter 2026 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio to Announce First Quarter 2026 Financial Results

TELA Bio Analysts Cut Their Forecasts After Q4 Results

TELA Bio, Inc. (TELA) Q4 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

TELA Bio Reports First Quarter 2026 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio, Inc. (TELA) Q1 2026 Earnings Call Transcript

TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates

TELA Bio Reports First Quarter 2026 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio to Announce First Quarter 2026 Financial Results

TELA Bio Analysts Cut Their Forecasts After Q4 Results

TELA Bio, Inc. (TELA) Q4 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

TELA Bio Reports First Quarter 2026 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)